Form 4: Vita Coco COO Exercises Options, Sells Shares

Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc., executed a pre-arranged transaction involving the exercise of stock options and subsequent sale of common stock.

Summary

• Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc. (COCO), acquired 3,173 shares of common stock on September 29, 2025, by exercising non-qualified stock options at an exercise price of $10.178 per share.
• Concurrently, Mr. Burth disposed of 3,173 shares of common stock on September 29, 2025, at a price of $42.5 per share.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan.
• Following these transactions, Mr. Burth beneficially owns 76,127 shares of common stock directly.
• Mr. Burth also holds various non-qualified stock options, with exercise prices ranging from $10.178 to $33.36, and expiration dates extending up to March 4, 2035.
• A significant portion of the remaining options are fully vested and currently exercisable, while others vest in annual installments over the coming years.

Sentiment

Score: 6

Explanation: The transaction is a routine insider sale following an option exercise, executed under a pre-arranged 10b5-1 plan. While a sale by an officer can sometimes be viewed cautiously, the execution under a plan mitigates negative sentiment, and the monetization of vested options is a normal part of executive compensation.

Positives

• The Chief Operating Officer monetized vested stock options, indicating a realization of value from his compensation package.
• The sale price of $42.5 per share is significantly higher than the exercise price of $10.178, demonstrating a substantial gain on the exercised options.

Negatives

• The sale of shares by an executive, even under a pre-arranged 10b5-1 plan, can sometimes be perceived by some investors as a lack of conviction, though this is mitigated by the pre-planned nature of the transaction.

Future Outlook

The filing does not provide forward-looking statements or guidance beyond the vesting schedules and expiration dates of the remaining stock options held by the reporting person.

Industry Context

This filing is a routine insider transaction report and does not contain information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Minimal direct impact on shareholders, as it represents a routine compensation-related transaction by an executive under a pre-arranged plan.

Next Steps

• Remaining non-qualified stock options will continue to vest according to their respective schedules, with some vesting in annual installments beginning on November 27, 2022, March 10, 2024, March 4, 2025, and August 15, 2025, and others on the anniversary of their grant date.

Key Dates

Keywords

Vita Coco, COCO, Jonathan Burth, SEC Form 4, Insider Trading, Stock Options, Rule 10b5-1, Officer Transaction, Chief Operating Officer